{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["COVID-19", "SARS-CoV-2", "ozone", "public health", "therapy"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32984235", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "30"}, "DateRevised": {"Year": "2021", "Month": "04", "Day": "30"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "08", "Day": "25"}], "ELocationID": ["417", "10.3389/fpubh.2020.00417"], "Journal": {"ISSN": "2296-2565", "JournalIssue": {"Volume": "8", "PubDate": {"Year": "2020"}}, "Title": "Frontiers in public health", "ISOAbbreviation": "Front Public Health"}, "ArticleTitle": "Ozone Therapy as a Possible Option in COVID-19 Management.", "Pagination": {"StartPage": "417", "MedlinePgn": "417"}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biosciences and Veterinary Medicine, University of Camerino, Matelica, Italy."}], "LastName": "Gavazza", "ForeName": "Alessandra", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biosciences and Veterinary Medicine, University of Camerino, Matelica, Italy."}], "LastName": "Marchegiani", "ForeName": "Andrea", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biosciences and Veterinary Medicine, University of Camerino, Matelica, Italy."}], "LastName": "Rossi", "ForeName": "Giacomo", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Oxygen-Ozone Therapy Scientific Society (SIOOT), Gorle, Italy."}, {"Identifier": [], "Affiliation": "Director of Comunian Clinic, Gorle, Italy."}], "LastName": "Franzini", "ForeName": "Marianno", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biosciences and Veterinary Medicine, University of Camerino, Matelica, Italy."}], "LastName": "Spaterna", "ForeName": "Andrea", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biosciences and Veterinary Medicine, University of Camerino, Matelica, Italy."}], "LastName": "Mangiaterra", "ForeName": "Sara", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biosciences and Veterinary Medicine, University of Camerino, Matelica, Italy."}], "LastName": "Cerquetella", "ForeName": "Matteo", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Public Health", "NlmUniqueID": "101616579", "ISSNLinking": "2296-2565"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": ["therapy"], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "CDC - How Coronavirus Spreads  Available online at: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covid-spreads.html (accessed March 31, 2020)."}, {"Citation": "Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ, et al. . Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. (2020) 9:29. 10.1186/s40249-020-00646-x", "ArticleIdList": ["10.1186/s40249-020-00646-x", "PMC7079521", "32183901"]}, {"Citation": "Li H, Zhou Y, Zhang M, Wang H, Zhao Q, Liu J. Updated approaches against SARS-CoV-2. Antimicrob Agents Chemother. (2020) 9:382\u20135. 10.1128/AAC.00483-20", "ArticleIdList": ["10.1128/AAC.00483-20", "PMC7269512", "32205349"]}, {"Citation": "Guo Y-R, Cao Q-D, Hong Z-S, Tan Y-Y, Chen S-D, Jin H-J, et al. . The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak \u2013 an update on the status. Mil Med Res. (2020) 7:1\u201310. 10.1186/s40779-020-00240-0", "ArticleIdList": ["10.1186/s40779-020-00240-0", "PMC7068984", "32169119"]}, {"Citation": "Bocci VA. Scientific and medical aspects of ozone therapy. State Art Arch Med Res. (2006) 37:425\u201335. 10.1016/j.arcmed.2005.08.006", "ArticleIdList": ["10.1016/j.arcmed.2005.08.006", "16624639"]}, {"Citation": "Elvis AM, Ekta JS. Ozone therapy: a clinical review. J Nat Sci Biol Med. (2011) 2:66\u201370. 10.4103/0976-9668.82319", "ArticleIdList": ["10.4103/0976-9668.82319", "PMC3312702", "22470237"]}, {"Citation": "Glew RH, Basu A, Shelley SA, Paterson JF, Diven WF, Montgomery MR, et al. . Sequential changes of lamellar body hydrolases during ozone-induced alveolar injury and repair. Am J Pathol. (1989) 134:1143\u201350.", "ArticleIdList": ["PMC1879901", "2719079"]}, {"Citation": "Balis JU, Paterson JF, Lundh JM, Haller EM, Shelley SA, Montgomery MR. Ozone stress initiates acute perturbations of secreted surfactant membranes. Am J Pathol. (1991) 138:847\u201357.", "ArticleIdList": ["PMC1886119", "2012173"]}, {"Citation": "Valacchi G, Fortino V, Bocci V. The dual action of ozone on the skin. Br J Dermatol. (2005) 153:1096\u2013100. 10.1111/j.1365-2133.2005.06939.x", "ArticleIdList": ["10.1111/j.1365-2133.2005.06939.x", "16307642"]}, {"Citation": "Mart\u00ednez-S\u00e1nchez G, Schwartz A, Donna VD. Potential cytoprotective activity of ozone therapy in SARS-CoV-2/COVID-19. Antioxidants (Basel). (2020) 9:389. 10.3390/antiox9050389", "ArticleIdList": ["10.3390/antiox9050389", "PMC7278582", "32384798"]}, {"Citation": "Valdenassi L, Franzini M, Ricevuti G, Rinaldi L, Galoforo AC, Tirelli U. Potential mechanisms by which the oxygen-ozone (O2-O3) therapy could contribute to the treatment against the coronavirus COVID-19. Eur Rev Med Pharmacol Sci. (2020) 24:4059\u201361. 10.26355/eurrev_202004_20976", "ArticleIdList": ["10.26355/eurrev_202004_20976", "32374009"]}, {"Citation": "Larini A, Bianchi L, Bocci V. The ozone tolerance: I) Enhancement of antioxidant enzymes is ozone dose-dependent in Jurkat cells. Free Radic Res. (2003) 37:1163\u20138. 10.1080/10715760310001604170", "ArticleIdList": ["10.1080/10715760310001604170", "14703728"]}, {"Citation": "Sechi LA, Lezcano I, Nunez N, Espim M, Dupre I, Pinna A, et al. . Antibacterial activity of ozonized sunflower oil (Oleozon). J Appl Microbiol. (2001) 90:279\u201384. 10.1046/j.1365-2672.2001.01235.x", "ArticleIdList": ["10.1046/j.1365-2672.2001.01235.x", "11168731"]}, {"Citation": "Wentworth P, McDunn JE, Wentworth AD, Takeuchi C, Nieva J, Jones T, et al. . Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science. (2002) 298:2195\u20139. 10.1126/science.1077642", "ArticleIdList": ["10.1126/science.1077642", "12434011"]}, {"Citation": "Ouf SA, Moussa TA, Abd-Elmegeed AM, Eltahlawy SR. Anti-fungal potential of ozone against some dermatophytes. Brazilian J Microbiol. (2016) 47:697\u2013702. 10.1016/j.bjm.2016.04.014", "ArticleIdList": ["10.1016/j.bjm.2016.04.014", "PMC4927674", "27287337"]}, {"Citation": "Dianzani MU. Lipid peroxidation and cancer. Crit Rev Oncol Hematol. (1993) 15:125\u201347. 10.1016/1040-8428(93)90052-6", "ArticleIdList": ["10.1016/1040-8428(93)90052-6", "8117415"]}, {"Citation": "Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. (1991) 11:81\u2013128. 10.1016/0891-5849(91)90192-6", "ArticleIdList": ["10.1016/0891-5849(91)90192-6", "1937131"]}, {"Citation": "Shacter E. Quantification and significance of protein oxidation in biological samples. Drug Metab Rev. (2000) 32:307\u201326. 10.1081/DMR-100102336", "ArticleIdList": ["10.1081/DMR-100102336", "11139131"]}, {"Citation": "Roy D, Wong PKY, Engelbrecht RS, Chian ESK. Mechanism of enteroviral inactivation by ozone. Appl Environ Microbiol. (1981) 41:718\u201323. 10.1128/AEM.41.3.718-723.1981", "ArticleIdList": ["10.1128/AEM.41.3.718-723.1981", "PMC243766", "6261692"]}, {"Citation": "Jiang HJ, Chen N, Shen ZQ, Yin J, Qiu ZG, Miao J, et al. . Inactivation of poliovirus by ozone and the impact of ozone on the viral genome. Biomed Environ Sci. (2019) 32:324\u201333. 10.3967/bes2019.044", "ArticleIdList": ["10.3967/bes2019.044", "31217049"]}, {"Citation": "Murray BK, Ohmine S, Tomer DP, Jensen KJ, Johnson FB, Kirsi JJ, et al. . Virion disruption by ozone-mediated reactive oxygen species. J Virol Methods. (2008) 153:74\u20137. 10.1016/j.jviromet.2008.06.004", "ArticleIdList": ["10.1016/j.jviromet.2008.06.004", "18598719"]}, {"Citation": "Rowen RJ, Robins H. A plausible \u201cpenny\u201d costing effective treatment for corona virus - ozone therapy. J Infect Dis Epidemiol. (2020) 6:113 10.23937/2474-3658/1510113", "ArticleIdList": ["10.23937/2474-3658/1510113"]}, {"Citation": "Hern\u00e1ndez A, Papadakos PJ, Torres A, Gonz\u00e1lez DA, Vives M, Ferrando C, et al. . Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19. Dos terapias conocidas podr\u00edan ser efectivas como adyuvantes en el paciente cr\u00edtico infectado por COVID-19. Rev Esp Anestesiol Reanim. (2020) 67:245\u201352. 10.1016/j.redar.2020.03.004", "ArticleIdList": ["10.1016/j.redar.2020.03.004", "PMC7156242", "32303365"]}, {"Citation": "Italian \u201cIstituto Superiore di Sanit\u00e0\u201d biocide COVID-19 working group \nRaccomandazioni ad interim sulla sanificazione di strutture non sanitarie nell'attuale emergenza COVID-19: superfici, ambienti interni e abbigliamento. Version 15th May 2020. Available online at: https://www.iss.it/rapporti-covid-19/-/asset_publisher/btw1J82wtYzH/content/id/5392909 (accessed July 06, 2020)."}, {"Citation": "Ricevuti G, Franzini M, Valdenassi L. Oxygen-ozone immunoceutical therapy in COVID-19 outbreak: facts and figures. Ozone Therapy. (2020) 5:9014 10.4081/ozone.2020.9014", "ArticleIdList": ["10.4081/ozone.2020.9014"]}, {"Citation": "Yan T, Xiao R, Lin G. Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: a double-edged sword? FASEB J. (2020) 34:6017\u201326. 10.1096/fj.202000782", "ArticleIdList": ["10.1096/fj.202000782", "PMC7264803", "32306452"]}, {"Citation": "Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. (2020) 46:586\u201390. 10.1007/s00134-020-05985-9", "ArticleIdList": ["10.1007/s00134-020-05985-9", "PMC7079879", "32125455"]}, {"Citation": "Scientific Society of Oxygen Ozone Therapy website  Available online at: http://backoffice.ossigenoozono.it/Multimedia/Content/LETTERA_UFFICIALE_ISS.pdf (accessed March 31, 2020)."}, {"Citation": "Scientific Society of Oxygen Ozone Therapy website\u2014report 7  Available online at: http://backoffice.ossigenoozono.it/Multimedia/Content/Report_n._7.pdf (accessed July 02, 2020)."}, {"Citation": "Scientific Society of Oxygen Ozone Therapy website\u2014report 8  Available online at: http://backoffice.ossigenoozono.it/Multimedia/Content/Report_n.8_-_English.pdf (accessed July 02, 2020)."}, {"Citation": "World Federation of Ozone Therapy website  Available online at: https://www.wfoot.org/last-news-ozone-and-covid19/ (accessed July 06, 2020)."}, {"Citation": "Zheng Z, Dong M, Hu K. A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19. J Med Virol. (2020). 10.1002/jmv.26040. [Epub ahead of print].", "ArticleIdList": ["10.1002/jmv.26040", "PMC7280732", "32437014"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "4", "Day": "6"}, {"Year": "2020", "Month": "7", "Day": "13"}, {"Year": "2020", "Month": "9", "Day": "28", "Hour": "5", "Minute": "45"}, {"Year": "2020", "Month": "9", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "29", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "8", "Day": "25"}], "PublicationStatus": "epublish", "ArticleIdList": ["32984235", "PMC7477102", "10.3389/fpubh.2020.00417"]}}], "PubmedBookArticle": []}